{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CBIO/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:52:55.117Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10260,"canonical_name":"CRESCENT BIOPHARMA, INC.","cik":"0001253689","uei":null,"lei":null,"duns":null,"ticker":"CBIO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":52},"count":52,"timeline":[{"ts":"2026-10-15","kind":"sec.filing","form_type":"8-K","title":"8-K — CRESCENT BIOPHARMA, INC. — 2026-10-15","url_slug":"/sec/cik-0001253689/8-k/0001628280-26-066006","accession_number":"0001628280-26-066006","importance":35},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062700","accession_number":"0001628280-26-062700","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062701","accession_number":"0001628280-26-062701","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062703","accession_number":"0001628280-26-062703","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062705","accession_number":"0001628280-26-062705","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062706","accession_number":"0001628280-26-062706","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062707","accession_number":"0001628280-26-062707","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/4/0001628280-26-062709","accession_number":"0001628280-26-062709","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"S-8","title":"S-8 — CRESCENT BIOPHARMA, INC. — 2026-09-18","url_slug":"/sec/cik-0001253689/s-8/0001628280-26-062634","accession_number":"0001628280-26-062634","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"144","title":"144 — CRESCENT BIOPHARMA, INC. — 2026-09-17","url_slug":"/sec/cik-0001253689/144/0001628280-26-062526","accession_number":"0001628280-26-062526","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"144","title":"144 — CRESCENT BIOPHARMA, INC. — 2026-09-17","url_slug":"/sec/cik-0001253689/144/0001628280-26-062529","accession_number":"0001628280-26-062529","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"144","title":"144 — CRESCENT BIOPHARMA, INC. — 2026-09-16","url_slug":"/sec/cik-0001253689/144/0001628280-26-062211","accession_number":"0001628280-26-062211","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"144","title":"144 — CRESCENT BIOPHARMA, INC. — 2026-09-16","url_slug":"/sec/cik-0001253689/144/0001628280-26-062213","accession_number":"0001628280-26-062213","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CRESCENT BIOPHARMA, INC. — 2026-07-31","url_slug":"/sec/cik-0001253689/effect/9999999995-26-002504","accession_number":"9999999995-26-002504","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CRESCENT BIOPHARMA, INC. — 2026-07-30","url_slug":"/sec/cik-0001253689/10-q/0001628280-26-050869","accession_number":"0001628280-26-050869","importance":45},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — CRESCENT BIOPHARMA, INC. — 2026-07-30","url_slug":"/sec/cik-0001253689/8-k/0001628280-26-050805","accession_number":"0001628280-26-050805","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"424B3","title":"424B3 — CRESCENT BIOPHARMA, INC. — 2026-07-30","url_slug":"/sec/cik-0001253689/424b3/0001628280-26-050881","accession_number":"0001628280-26-050881","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"POS AM","title":"POS AM — CRESCENT BIOPHARMA, INC. — 2026-07-30","url_slug":"/sec/cik-0001253689/pos-am/0001628280-26-050885","accession_number":"0001628280-26-050885","importance":30},{"ts":"2026-07-20","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — CRESCENT BIOPHARMA, INC. — 2026-07-20","url_slug":"/sec/cik-0001253689/schedule-13d-a/0001104659-26-085114","accession_number":"0001104659-26-085114","importance":70},{"ts":"2026-07-20","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-07-20","url_slug":"/sec/cik-0001253689/4/0001104659-26-085113","accession_number":"0001104659-26-085113","importance":30},{"ts":"2026-07-16","kind":"sec.insider.p","reporter":"Fairmount Funds Management LLC","title":"","shares":853450,"price_per_share":14.5,"usd_value":12375025,"security_title":"Ordinary Shares","importance":62.375025},{"ts":"2026-07-16","kind":"sec.insider.p","reporter":"Fairmount Healthcare Fund II L.P.","title":"","shares":853450,"price_per_share":14.5,"usd_value":12375025,"security_title":"Ordinary Shares","importance":62.375025},{"ts":"2026-07-16","kind":"sec.insider.p","reporter":"Kiselak Tomas","title":"","shares":853450,"price_per_share":14.5,"usd_value":12375025,"security_title":"Ordinary Shares","importance":62.375025},{"ts":"2026-07-16","kind":"sec.insider.p","reporter":"Harwin Peter Evan","title":"","shares":853450,"price_per_share":14.5,"usd_value":12375025,"security_title":"Ordinary Shares","importance":62.375025},{"ts":"2026-07-15","kind":"sec.filing","form_type":"8-K","title":"8-K — CRESCENT BIOPHARMA, INC. — 2026-07-15","url_slug":"/sec/cik-0001253689/8-k/0001628280-26-048347","accession_number":"0001628280-26-048347","importance":35},{"ts":"2026-07-15","kind":"sec.filing","form_type":"424B5","title":"424B5 — CRESCENT BIOPHARMA, INC. — 2026-07-15","url_slug":"/sec/cik-0001253689/424b5/0001628280-26-048344","accession_number":"0001628280-26-048344","importance":30},{"ts":"2026-07-14","kind":"sec.filing","form_type":"8-K","title":"8-K — CRESCENT BIOPHARMA, INC. — 2026-07-14","url_slug":"/sec/cik-0001253689/8-k/0001628280-26-048151","accession_number":"0001628280-26-048151","importance":35},{"ts":"2026-07-14","kind":"sec.filing","form_type":"424B5","title":"424B5 — CRESCENT BIOPHARMA, INC. — 2026-07-14","url_slug":"/sec/cik-0001253689/424b5/0001628280-26-048144","accession_number":"0001628280-26-048144","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CRESCENT BIOPHARMA, INC. — 2026-07-10","url_slug":"/sec/cik-0001253689/effect/9999999995-26-002258","accession_number":"9999999995-26-002258","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"S-3","title":"S-3 — CRESCENT BIOPHARMA, INC. — 2026-07-01","url_slug":"/sec/cik-0001253689/s-3/0001628280-26-046544","accession_number":"0001628280-26-046544","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044884","accession_number":"0001628280-26-044884","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044885","accession_number":"0001628280-26-044885","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044886","accession_number":"0001628280-26-044886","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044887","accession_number":"0001628280-26-044887","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044890","accession_number":"0001628280-26-044890","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044892","accession_number":"0001628280-26-044892","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-23","url_slug":"/sec/cik-0001253689/4/0001628280-26-044893","accession_number":"0001628280-26-044893","importance":30},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Brumm Joshua T","title":"Chief Executive Officer","shares":42305,"price_per_share":17.99,"usd_value":761067,"security_title":"Ordinary Shares","importance":35.76106695},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"McNeill Jonathan","title":"President and COO","shares":20549,"price_per_share":17.99,"usd_value":369677,"security_title":"Ordinary Shares","importance":35.36967651},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Pinkas Jan","title":"Chief Scientific Officer","shares":1288,"price_per_share":17.99,"usd_value":23171,"security_title":"Ordinary Shares","importance":35.02317112},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Im Ellie Eunkyung","title":"Chief Medical Officer","shares":1219,"price_per_share":17.99,"usd_value":21930,"security_title":"Ordinary Shares","importance":35.02192981},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Bispham Barbara Harlin","title":"See Remarks","shares":1218,"price_per_share":17.99,"usd_value":21912,"security_title":"Ordinary Shares","importance":35.02191182},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Scalzo Richard William","title":"Chief Financial Officer","shares":1112,"price_per_share":17.99,"usd_value":20005,"security_title":"Ordinary Shares","importance":35.02000488},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Lynch Ryan","title":"See Remarks","shares":465,"price_per_share":17.99,"usd_value":8365,"security_title":"Ordinary Shares","importance":35.00836535},{"ts":"2026-06-22","kind":"sec.filing","form_type":"10-Q/A","title":"10-Q/A — CRESCENT BIOPHARMA, INC. — 2026-06-22","url_slug":"/sec/cik-0001253689/10-q-a/0001628280-26-044713","accession_number":"0001628280-26-044713","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"424B3","title":"424B3 — CRESCENT BIOPHARMA, INC. — 2026-06-22","url_slug":"/sec/cik-0001253689/424b3/0001628280-26-044718","accession_number":"0001628280-26-044718","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — CRESCENT BIOPHARMA, INC. — 2026-06-03","url_slug":"/sec/cik-0001253689/8-k/0001628280-26-040051","accession_number":"0001628280-26-040051","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-03","url_slug":"/sec/cik-0001253689/4/0001628280-26-040575","accession_number":"0001628280-26-040575","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-03","url_slug":"/sec/cik-0001253689/4/0001628280-26-040577","accession_number":"0001628280-26-040577","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-03","url_slug":"/sec/cik-0001253689/4/0001628280-26-040580","accession_number":"0001628280-26-040580","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-03","url_slug":"/sec/cik-0001253689/4/0001628280-26-040582","accession_number":"0001628280-26-040582","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — CRESCENT BIOPHARMA, INC. — 2026-06-03","url_slug":"/sec/cik-0001253689/4/0001628280-26-040583","accession_number":"0001628280-26-040583","importance":30}]}